Clik here to view.
Cancer-detection nets entrepreneurial award
Ban-An Khaw, a pharmaceutical sciences professor in the Bouvé College of Health Sciences, was recently named a finalist for this year’s MassChallenge, an annual $1M global startup competition and...
View ArticleClik here to view.
Drug discovery symposium maps new frontiers, collaborations
More than 300 students, faculty and industry researchers from more than 80 institutions convened at Northeastern University on Tuesday for a daylong symposium on the future of drug discovery and...
View ArticleClik here to view.
Northeastern researchers work to keep hospital-acquired staph infections in...
Hospital-related staph infections are rampant. In 2005 alone there were an estimated 478,000 cases in the U.S., according to the Centers for Disease Control and Prevention. The numbers are dropping,...
View ArticleClik here to view.
Professor named to national committee on drug affordability, access
The fallout over EpiPen pricing continues. On Monday, a group of U.S. senators challenged the pharmaceutical company Mylan, which owns the device, to refund $50 million to the Department of Defense....
View ArticleCalling attention to neglected diseases
Chemistry professor Michael Pollastri and his team of 12 post-doctoral, graduate and undergraduate students are combining their science skills and idealism to bring attention — and solutions — to...
View Article3Qs: From drug development to treating disease
Last month, the Massachusetts-based pharmaceutical company Vertex announced that the federal Food and Drug Administration had approved its new drug to treat Hepatitis C, Incivek. The drug took two...
View ArticleClik here to view.
How one Northeastern spinoff is using origami to speed up drug development
To Northeastern engineering professor Carol Livermore, origami is more than just beautiful art—it’s a platform to create life-saving innovations in science and medicine. Since 2015, a research team...
View Article
